Related Experiment Video

Updated: Aug 8, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Successful treatment of post-mitral valve annuloplasty Aspergillus flavus endocarditis

D K Wagner, P H Werner, L I Bonchek

    The American Journal of Medicine
    |December 1, 1985
    PubMed

    Insights

    Aspergillus endocarditis has a high mortality rate. This case report details the first successful treatment of Aspergillus flavus endocarditis after mitral valve annuloplasty using surgery and antifungals.

    Area of Science:

    • Cardiology
    • Infectious Diseases
    • Mycology

    Background:

    • Aspergillus endocarditis is a rare and often fatal infection.
    • Mortality rates for Aspergillus endocarditis exceed 95% in reported cases.
    • Fungal endocarditis poses significant diagnostic and therapeutic challenges.

    Observation:

    • A patient developed Aspergillus flavus endocarditis following mitral valve annuloplasty.
    • The infection involved the prosthetic annuloplasty ring.
    • Previous literature documented only two survivors of Aspergillus endocarditis.

    Findings:

    • Successful recovery was achieved with a combination of surgical intervention and antifungal therapy.
    • This represents the first documented case of successful treatment for Aspergillus flavus endocarditis.
    • It is also the first reported successful treatment involving an annuloplasty ring.

    Implications:

    • This case highlights the potential for successful management of Aspergillus endocarditis with aggressive combined therapy.
    • It offers hope for patients with this devastating infection, particularly those with prosthetic material involvement.
    • Further research into optimal treatment strategies for fungal endocarditis is warranted.

    More Related Videos

    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

    Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

    Published on: May 26, 2023

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

    Published on: August 26, 2025

    Related Concept Videos

    Mitral Regurgitation III: Medical Management01:25

    Mitral Regurgitation III: Medical Management

    Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

    Mitral Stenosis II: Clinical features and Diagnostic Tests

    Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...